Image For Activity Cover
Myocardial Perfusion Imaging After CCTA: What Are We Looking For?
Faculty
Faculty:
Sharmila Dorbala, MD, MPH, MASNC
Brigham and Women's Hospital
Harvard Medical School
Boston, MA

Disclosures:
Advisory Board- Pfizer, GE Healthcare, Janssen, Eidos; Research Grants-Pfizer, GE Healthcare, Attralus; Speaking Fee-Ionetix

Ron Blankenstein, MD, FASNC
Brigham and Women's Hospital
Harvard Medical School
Boston, MA

Disclosures:
Research Grants – Amgen, Novartis; Consultant – Amgen, Novartis, Silence Therapeutics, Caristo Inc, Star Therapeutics, Roivant Science

Panelists:
Mouaz AL-Mallah, MD, MSc, FASNC
Houston Methodist
Houston, TX

Disclosures:
Research Grant - Siemens; Consultant – Phillips, Jubilant, Pfizer

Dennis Calnon, MD, MASNC
McConnell Heart Hospital at Riverside Methodist Hospital
OhioHealth Heart and Vascular Physician
Columbus, OH

No Disclosures

Randall C. Thompson, MD, MASNC
St. Luke's Mid America Heart Institute
Kansas, City, MO

No Disclosures
Learner Objectives
Upon completion of this module, learner will be able to:

• Discuss the role of myocardial perfusion imaging (MPI) in patients with chest pain in the current multimodality imaging environment
• Provide case-based learning on the appropriate use of MPI across the spectrum of chest pain patients
• Find an optimal pathway to risk-stratify, diagnose and treat chest pain patients.
Summary
Availability: Retired
Cost: FREE
Credit Offered:
No Credit Offered
Powered By